The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

The coroner is concerned that the medication's rare side effects do not receive enough attention when it is prescribed to patients. 

The new-look DCB was designed to provide care with a significantly lower drug load than similar devices. 

Did your facility make the cut? For its 2023-2024 list, U.S. News and World Report evaluated data from 119 hospitals and surveyed thousands of pediatric specialists.

While cardiac damage reverses in many patients following treatment, it can actually continue to get worse in others. 

Patient names, addresses, social security numbers and even medical histories were exposed as a result of the attack, which went unnoticed for more than two months. 

Contact force-sensing catheters were developed to help overcome the issue of incomplete ablation lesions.

"Psychologists have had little involvement in the care of cardiac patients but this needs to change," one researcher said in a statement. 

The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.

Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.